Learn more

ONTARIO CANCER INST

Overview
  • Total Patents
    85
About

ONTARIO CANCER INST has a total of 85 patent applications. Its first patent ever was published in 1960. It filed its patents most often in United States, Canada and EPO (European Patent Office). Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are AMGEN CANADA INC, UNIV HAMBURG EPPENDORF and HSC RES DEV CORP.

Patent filings per year

Chart showing ONTARIO CANCER INSTs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Mak Tak W 21
#2 Gariepy Jean 12
#3 Ling Victor 9
#4 Mak Tak Wah 7
#5 Foster Francis S 5
#6 Haq Rizwan 4
#7 Randall Susan 4
#8 Penninger Josef Martin 4
#9 Zanke Brent 4
#10 Midmer Michael 4

Latest patents

Publication Filing date Title
US7208468B2 Verotoxin pharmaceutical compositions and medical treatments therewith
CA2395284A1 Inhibition of gsk-3.beta.
CA2319720A1 Cytotoxic heteromeric protein combinatorial libraries
CA2251249A1 Cdc2-related kinase associated with acute leukemia
CA2243784A1 Cdc2-related kinase associated with acute leukemia
CA2222993A1 A method for using a ribosome-inactivating protein complex as a structural template and a molecular search engine in the design, construction and screening of combinatorial protein libraries
CA2245762A1 A method for selectively purging cd77+ cells from bone marrow
WO9707402A1 Protein fibril assembly assay
US5801145A Method for selectively purging CD77+ cells from bone marrow
US5698765A Mouse having a disrupted CD4 gene
US5731490A Mutant mouse lacking the expression of interferon regulatory factor 1 (IRF-1)
US5532158A Interleukin-2 receptor deficient mammals
US5684222A Mutant mouse having a disrupted TNFRp55
US5674977A Branched synthetic peptide conjugate
AU6918794A Mammals lacking expression of CD28 transgenic
AU6760794A Transgenic mammals lacking expression of particular cd45 isoforms
US5625122A Mouse having a disrupted lck gene
US5675059A Mouse lacking the expression of interferon regulatory factor 2 (IRF-2)
US5530178A Mutant mouse lacking CD8 surface marker
WO9323425A1 Metal chelating peptide